Choi 2008.
Methods |
|
|
Participants |
|
|
Interventions | Treatment group
Control group
|
|
Outcomes |
|
|
Notes |
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Insufficient information to permit judgement |
Allocation concealment (selection bias) | Unclear risk | Insufficient information to permit judgement |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Open‐label design thus no blinding of investigators or participants. However, unlikely to have impacted on objective clinical outcomes (e.g. urine volume) |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Insufficient information to permit judgement |
Incomplete outcome data (attrition bias) All outcomes | High risk | Large number of patients voluntarily changed to the low GDP PD solution (36/104 (35%)). Per protocol analysis |
Selective reporting (reporting bias) | Low risk | All appropriate outcomes reported |
Other bias | Unclear risk | Insufficient information to permit judgement |